Presidency: in February, Lithuania will receive 200 thousand. coronavirus vaccines



[ad_1]

According to Simonas Krėpšta, already in February Lithuania will receive about 200 thousand. doses of coronavirus vaccines.

According to him, the offer will increase after the European Medical Agency approves the vaccine developed by AstraZeneca. The decision is scheduled for Friday.

Photo by Luke April / 15min / Simonas Krėpšta

Photo by Luke April / 15min / Simonas Krėpšta

“This will be the third manufacturer to supply vaccines to all EU countries. Given the already existing supply from Pfizer’s company Moderna, this means that Lithuania can be expected to receive more than 200,000 in February. Vaccines,” he said S. Krėpšta on LRT radio on Thursday.

“In the second half of February, the number of vaccines will be such that about 10,000 vaccines can be carried out,” he added.

According to the president’s adviser, the supply of vaccines to Lithuania will continue to grow exponentially.

In the second half of February, the number of vaccines will be such that about 10,000 can be made. vaccinations

“The fact is that the availability of vaccines for EU countries will grow exponentially until the summer. We can see the January number, in total Lithuania received about 110 thousand. vaccinations But in February, we see, the growth is already twice, and it is very likely that in March, April and May, that growth will be exponential, ”said S.Krėpšta.

“If you can say that, now we are vaccinating and moving forward on the first track, it looks like the vaccination machine will be activated on the second track in February and so on,” he said.

President Gitanas Nausėda has previously said that around 70% of COVID-19 should be vaccinated in Lithuania in mid-summer. or about 2 million. population of the country.

According to G.Nausėda, this objective will not be changed by the knowledge of the pharmaceutical company AstraZeneca about the supply of vaccines to Lithuania lower than planned.

Last month, EU residents began getting vaccinated with the BioNTech and Pfizer vaccines, and Moderna approved the vaccine in early January.



[ad_2]